No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said
The group did not review information regarding tirzepatide, the medication used in drugs sold as Mounjaro and Zepbound.

Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Business Economic Syndicated News Mar 13, 2022
Business Economic Syndicated News Feb 22, 2025
Twin Path Ventures secures a £10m commitment from British Business Investments to...
Business Economic Syndicated News Feb 18, 2025
Property sales climbed 15% in January as UK buyers scrambled to beat the new stamp...
Business Economic Syndicated News Feb 18, 2025
Generative AI is getting better at interpreting dense texts, and this progress has...
Moderator Feb 16, 2025
Apple is planning to add Apple Intelligence to its Vision Pro headset in an update...
Business Economic Syndicated News Feb 11, 2025
Explore the different types of AI agents: their benefits, challenges, implementation,...